Fever is the body’s primary defense response — a regulated rise in temperature designed to slow bacterial replication and activate immune cells. Most fevers resolve within days. When fever persists for weeks despite no identifiable infection, that’s a fundamentally different clinical situation — and one that demands a thorough investigation.
Cancer accounts for approximately 20–30% of fever of unknown origin (FUO) cases in adults. Understanding why tumors cause fever, which cancers do it most often, and what other clues accompany a cancer-related fever is essential for anyone dealing with a persistent temperature that won’t resolve.
What Is Fever of Unknown Origin?
FUO has a precise clinical definition: temperature greater than 38.3°C (101°F) on multiple occasions, persisting for more than 3 weeks, without a diagnosis after at least 3 days of inpatient investigation or 3 outpatient visits. The key word is “unknown” — FUO is fever that has been actively investigated with standard tests and still has no explanation.
The three main categories of FUO in adults: infections (~30%), malignancy (~20–30%), and non-infectious inflammatory conditions — autoimmune and rheumatologic diseases (~15–20%). In adults over 40, malignancy becomes increasingly likely as a cause.
How Cancer Causes Persistent Fever
Paraneoplastic Fever (Most Common)
Tumor cells and the macrophages they activate release interleukins (IL-1, IL-6), TNF-α, and interferons. These cytokines stimulate prostaglandin E2 (PGE2) synthesis in the hypothalamus, resetting the thermostat upward. This is genuine fever — involving actual thermoregulatory changes. Because PGE2 is the mediator, NSAIDs (which block PGE2) can suppress this type of fever. This is the basis of the naproxen test.
Tumor Necrosis
Large, rapidly growing tumors develop central necrosis — the interior outgrows its blood supply and begins to die. Necrotic tissue releases pyrogenic material into the bloodstream, producing fever that can be sustained and difficult to control with standard antipyretics.
Secondary Infection from Obstruction
A pancreatic cancer obstructing the bile duct causes ascending cholangitis. A lung cancer obstructing a bronchus causes post-obstructive pneumonia. The fever here is from the infection — but the cancer is the underlying cause. Treatment requires both addressing the infection and managing the obstructing tumor.
The Pel-Ebstein Pattern
One of the most historically distinctive fever patterns in oncology, Pel-Ebstein fever describes a cyclical pattern in Hodgkin lymphoma: days to weeks of elevated temperature alternating with afebrile periods in a regular cycle. Named for two 19th-century physicians who independently described it, Pel-Ebstein fever is rare (5–10% of Hodgkin cases) but is considered highly suggestive when a young patient presents with cyclical fever, unexplained lymphadenopathy, and constitutional symptoms.
Which Cancers Cause Persistent Fever?
| Cancer | Mechanism | Key Features |
|---|---|---|
| Hodgkin Lymphoma | Cytokines (IL-6, TNF-α) | B symptom; ~30% at diagnosis; Pel-Ebstein pattern |
| Non-Hodgkin Lymphoma | Cytokines | Aggressive subtypes (DLBCL, Burkitt) most common |
| AML/Leukemia | Cytokines + neutropenic infection | Distinguish tumor fever from neutropenic fever — treatment differs |
| Renal Cell Carcinoma | Ectopic IL-6, paraneoplastic | “Internist’s tumor”; fever in ~20%; may precede urinary symptoms |
| Hepatocellular Carcinoma | Tumor necrosis + cytokines | Often on cirrhotic background; fever may be attributed to liver disease |
| Atrial Myxoma | IL-6 production by tumor | Rare cardiac tumor; triad: emboli + obstruction + constitutional symptoms; mimics lymphoma |
The B Symptoms in Lymphoma
In lymphoma staging (Ann Arbor system), three symptoms together constitute “B symptoms” and change the stage designation, prognosis, and treatment approach:
- Unexplained fever greater than 38°C
- Drenching night sweats
- Unexplained weight loss greater than 10% of body weight in the preceding 6 months
Presence of B symptoms = Stage IIB rather than IIA — typically indicating more aggressive disease and more intensive treatment. Any patient with all three B symptoms and palpable lymphadenopathy needs expedited hematology evaluation.
The Naproxen Test
The naproxen test uses the mechanism of paraneoplastic fever to help distinguish it from infectious fever. Since cancer fever is mediated by PGE2 (which naproxen blocks), tumor-related fever often resolves with naproxen while infectious fever typically does not.
Protocol: Naproxen 375 mg twice daily for 3 days. Complete resolution of fever = positive test, suggesting malignant or inflammatory (not infectious) etiology.
Limitations: The test is not specific — tuberculosis also responds to naproxen. A positive naproxen test adds clinical information but does not replace investigation. It should not be used to conclude “this isn’t cancer” if other red flags are present.
When Persistent Fever Requires Urgent Evaluation
- Significant weight loss + palpable lymph nodes → lymphoma, evaluate within days
- Pallor + easy bruising or bleeding → AML, CBC same day
- Right upper quadrant pain or jaundice → HCC or biliary obstruction
- Hematuria or flank mass → renal cell carcinoma
- Fever not responding to antibiotics after 5–7 days in outpatient setting
- Cyclical fever pattern (Pel-Ebstein) → lymphoma evaluation
What the Workup Looks Like
- CBC with differential — blasts (AML), lymphocytosis (CLL), thrombocytopenia
- Comprehensive metabolic panel — liver function (hepatic involvement), kidney function
- LDH, ESR, CRP, ferritin — markedly elevated in lymphoma; extremely high ferritin (>10,000) suggests HLH or aggressive lymphoma
- Blood cultures ×2 — endocarditis, bacteremia
- Chest X-ray — mediastinal widening (Hodgkin lymphoma), pneumonia, mass
- CT chest/abdomen/pelvis — if initial evaluation non-diagnostic
- PET-CT + lymph node biopsy — if lymphoma suspected
Frequently Asked Questions
References
- Mourad O, et al. Fever of Unknown Origin: A Systematic Review. J Hosp Med. 2020.
- Lister TA, et al. Ann Arbor classification. J Clin Oncol. 1989.
- NCCN Clinical Practice Guidelines: Hodgkin Lymphoma. Version 2024.
- Dinarello CA. Infection, fever, and exogenous and endogenous pyrogens. Clin Infect Dis. 2004.
- Bleeker-Rovers CP, et al. A prospective multicenter study on fever of unknown origin. Medicine. 2007.
- Cunha BA. Fever of unknown origin: the cancer connection. Infect Dis Clin North Am. 2017.

